31 – 40 of 70
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Higher levels of myelin are associated with higher resistance against tau pathology in Alzheimer’s disease
- Contribution to journal › Article
-
Mark
Amyloid-associated increases in soluble tau relate to tau aggregation rates and cognitive decline in early Alzheimer's disease
- Contribution to journal › Article
- 2021
-
Mark
Pathological drivers of neurodegeneration in suspected non-Alzheimer’s disease pathophysiology
- Contribution to journal › Article
-
Mark
The impact of amyloid burden and APOE on rates of cognitive impairment in late life depression
- Contribution to journal › Article
-
Mark
Comparing ATN-T designation by tau PET visual reads, tau PET quantification, and CSF PTau181 across three cohorts
- Contribution to journal › Article
-
Mark
Plasma phosphorylated tau181 and neurodegeneration in Alzheimer’s disease
- Contribution to journal › Article
-
Mark
Prediction of future Alzheimer’s disease dementia using plasma phospho-tau combined with other accessible measures
- Contribution to journal › Article
-
Mark
Tau PET correlates with different Alzheimer’s disease-related features compared to CSF and plasma p-tau biomarkers
- Contribution to journal › Article
-
Mark
DeepAtrophy : Teaching a neural network to detect progressive changes in longitudinal MRI of the hippocampal region in Alzheimer's disease
- Contribution to journal › Article
-
Mark
Personalized prediction of progression in pre-dementia patients based on individual biomarker profile : A development and validation study
- Contribution to journal › Article
